Anima Biotech

75 Claremont Rd
Ste 102
Bernardsville
NJ
07924
United States

Email: anima@animabiotech.com

Show articles for this employer

About Anima Biotech

Anima Biotech is advancing mRNA Lightning, a novel platform for the discovery of small molecule mRNA drugs and their mechanisms of action. Our differentiated approach combines high scale phenotypic screening that automates millions of experiments in live mRNA biology with MOAi technology using AI to elucidate the mechanism of action of active molecules.

Our approach has been validated by our collaborations with Lilly, Takeda Pharmaceuticals and AbbVie and a broad pipeline across 20 different discovery programs in various therapeutic areas. With our deep expertise in mRNA biology, we were able to advance our programs at an unprecedented speed and success rate.

Anima's wholly owned pipeline is in Immunology (Collagen I mRNA biology modulators, preclinical stage in lung fibrosis and applicable across many fibrotic diseases), Oncology (c-Myc mRNA biology modulators and mutation agnostic mKras mRNA biology modulators), and Neuroscience (Tau - Alzheimer's disease and Pain - Nav1.7 mRNA biology modulators). Our science was further validated with seven patents, 15 peer-reviewed publications and 17 scientific collaborations.

Currently, there are no jobs for this employer on BioSpace.

Browse jobs with BioSpace Featured Employers here.